Personalized Approach to Tissue and Liquid Biopsy after Failure of First-Line EGFR-TKIs: Is There an Issue When Tissue Is Not the Issue? A Case Series

Personalized Approach to Tissue and Liquid Biopsy after Failure of First-Line EGFR-TKIs: Is There an Issue When Tissue Is Not the Issue? A Case Series

Traditionally, tissue availability from rebiopsy is a prerequisite for adequate sequencing of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in therapy for advanced-stage lung cancer. Tissue biopsy truly is the gold standard for genetic analyses, but in some cases, such as w...

Full description

Bibliographic Details
Main Authors: Daliborka Bursac, Bojan Zarić, Tomi Kovačević, Vladimir Stojšić, Anastasios Vagionas, Ioannis Boukovinas, Kosmas Tsakiridis, Christoforos Kosmidis, Konstantinos Sapalidis, Konstantinos Romanidis, Nikolaos Courcoutsakis, Dimitris Matthaios, Paul Zarogoulidis, Chrysanthi Sardeli, Vanesa Sekerus
Format: Article
Language:English
Published: Karger Publishers 2021-05-01
Series:Case Reports in Oncology
Subjects:
liquid biopsy
osimertinib
t790m mutation
tissue biopsy
Online Access:https://www.karger.com/Article/FullText/515506

Internet

https://www.karger.com/Article/FullText/515506

Similar Items